We are monitoring the impact of COVID-19 on Generic Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2090
Share on
Share on

Global Generic Drugs Market Analysis – By Type (Pure Generic Drugs, Branded Generic Drugs), Application (Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory, Others), Region - Industry Size, Share, Trends, Forecast, Growth | 2019 - 2024

Pulished: February, 2020
ID: 2090
Pages: 175

Generic Drugs Market Size & Growth (2019 - 2024)

The size of the Global Generic Drugs Market was worth USD 290.83 billion in 2019 and is expected to reach USD 412.50 billion by 2024, growing at a CAGR of 7.24% during the forecast period 2019 - 2024.

The increase in the incidence of chronic diseases is a significant driver of the global generic drugs market. The cost increase in existing medicines is also the factor that is responsible for Global Generic Drugs Market growth. The cost-effective and availability of drugs is driving business growth. The popularity of chronic diseases and existing markets drive the generic drugs market growth.

The lack of having knowledge about the generic drug market is the curb to the worldwide market. In developing countries, drugs are cheap, but the quality is restraining growth.

Emerging markets like India and China are supposed to generate more opportunities for the generic drugs market. 

High competition and shortage of drugs are restraining the Global Generic Drugs Market. Prescription of doctors is affecting the growth because the doctors are prescribing branded drugs/medicines to the patients. Biosimilar developers focus on proteins of highly complicated, high cost and even more world experience of manufacturing, which will be challenging to follow existing processes for proving a high degree of similarity.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Type, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Analysed

Ranbaxy Laboratories, Ltd, Actavis, Mylan, Inc., Industries, Ltd., Dr. Reddy’s Laboratories, Par Pharmaceutical, Inc., Sandoz International GmbH, Hospira, Inc., Apotex, Inc., Watson Pharmaceuticals, Ltd., Teva Pharmaceutical and others

 

This research report on the Global Generic Drugs Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Generic Drugs Market Analysis - By Type:

  • Pure Generic Drugs
  • Branded Generic Drugs

Generic Drugs Market Analysis - By Application:

  • The Central Nervous System (CNS)
  • Cardiovascular
  • Dermatology
  • Oncology
  • Respiratory
  • Others

Regional Analysis:

North America held the most substantial share value in the Global Generic Drugs Market during the forecast period. This is mainly due to the prescription patterns that are mostly covered with branded generic drugs. Hence, the demand for the market is high in this region. Europe is anticipated to have a significant growth which is due to an increase in the commonness of chronic diseases and government support for the generic drug market.

Nations like India and China in the Asia-Pacific region dominated the global generic drugs business in terms of volume. India is leading in this region due to the number of Indian companies waiting for approval in the U.S and other countries.

In Latin America, Brazil was the largest generic drug market due to the sale of the drugs, which is leading in the biopharmaceutical sector by value and by volume. This nation is foreseen to remain in power and influence in this region, owing to high demand and a rise in development in the pharmaceutical sector.

List of key market participants leading the Global Generic Drugs Market profiled in the report are:

  1. Ranbaxy Laboratories, Ltd
  2. Actavis
  3. Mylan, Inc.
  4. Dr. Reddy’s Laboratories
  5. Par Pharmaceutical, Inc.
  6. Sandoz International GmbH
  7. Hospira, Inc.
  8. Apotex, Inc.
  9. Watson Pharmaceuticals, Ltd
  10. Teva Pharmaceutical

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Biosimilars               

                                5.1.3 simple generics     

                                5.1.4 Super generics      

                                5.1.5  Y-o-Y Growth Analysis, By Product              

                                5.1.6  Market Attractiveness Analysis, By Product            

                                5.1.7  Market Share Analysis, By Product              

                5.2 Therapeutic drugs                   

                                5.2.1 Introduction           

                                5.2.2 Cardiovascular Products    

                                5.2.3 Anti-infective Drugs            

                                5.2.4 Anti Arthritis Drugs              

                                5.2.5 Central Nervous System Drugs       

                                5.2.6 Anti Cancer Drugs

                                5.2.7 Respiratory System Drugs

                                5.2.8 Others      

                                5.2.9 Y-o-Y Growth Analysis, By Therapeutic Drugs          

                                5.2.10 Market Attractiveness Analysis, By Therapeutic Drugs      

                                5.2.11 Market Share Analysis, By Therapeutic Drugs        

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Therapeutic Drugs

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Therapeutic Drugs

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By type

                                                6.1.5.3 By Therapeutic Drugs

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Ranbaxy Laboratories                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Actavis                          

                8.3 Mylan, Inc. Industries, Ltd.                  

                8.4 Dr. Reddy’s Laboratories                      

                8.5 Par Pharmaceutical, Inc.                        

                8.6 Sandoz International GmbH                

                8.7 Celgene Corporation                              

                8.8 Apotex, Inc.                               

                8.9 Watson Pharmaceuticals, Ltd.                            

                8.10 Teva Pharmaceutical and others.                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Generic Drugs Market By Region, From 2019-2024 ( USD Billion )
  2. Global Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  3. Global Biosimilars Market By Region, From 2019-2024 ( USD Billion )
  4. Global Simple Generics Market By Region, From 2019-2024 ( USD Billion )
  5. Global Super Generics Market By Region, From 2019-2024 ( USD Billion )
  6. Global Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  7. Global Cardiovascular Drugs Market By Region, From 2019-2024 ( USD Billion )
  8. Global Anti-Infective Drugs Market By Region, From 2019-2024 ( USD Billion )
  9. Global Anti-Arthritic Drugs Market By Region, From 2019-2024 ( USD Billion )
  10. Global Central Nervous system Drugs Market By Region, From 2019-2024 ( USD Billion )
  11. Global Anti-Cancer Drugs Market By Region, From 2019-2024 ( USD Billion )
  12. Global Respiratory Products Market By Region, From 2019-2024 ( USD Billion )
  13. Global Others Market By Region, From 2019-2024 ( USD Billion )
  14. North America Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  15. North America Biosimilars Market By Region, From 2019-2024 ( USD Billion )
  16. North America Simple Generics Market By Region, From 2019-2024 ( USD Billion )
  17. North America Super Generics Market By Region, From 2019-2024 ( USD Billion )
  18. North America Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  19. North America Cardiovascular Drugs Market By Region, From 2019-2024 ( USD Billion )
  20. North America Anti-Infective Drugs Market By Region, From 2019-2024 ( USD Billion )
  21. North America Anti-Arthritic Drugs Market By Region, From 2019-2024 ( USD Billion )
  22. North America Central Nervous system Drugs Market By Region, From 2019-2024 ( USD Billion )
  23. North America Anti-Cancer Drugs Market By Region, From 2019-2024 ( USD Billion )
  24. North America Respiratory Products Market By Region, From 2019-2024 ( USD Billion )
  25. North America Others Market By Region, From 2019-2024 ( USD Billion )
  26. United States Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  27. United States Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  28. Canada Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  29. Canada Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  30. Europe Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  31. Europe Biosimilars Market By Region, From 2019-2024 ( USD Billion )
  32. Europe Simple Generics Market By Region, From 2019-2024 ( USD Billion )
  33. Europe Super Generics Market By Region, From 2019-2024 ( USD Billion )
  34. Europe Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  35. Europe Cardiovascular Drugs Market By Region, From 2019-2024 ( USD Billion )
  36. Europe Anti-Infective Drugs Market By Region, From 2019-2024 ( USD Billion )
  37. Europe Anti-Arthritic Drugs Market By Region, From 2019-2024 ( USD Billion )
  38. Europe Central Nervous system Drugs Market By Region, From 2019-2024 ( USD Billion )
  39. Europe Anti-Cancer Drugs Market By Region, From 2019-2024 ( USD Billion )
  40. Europe Respiratory Products Market By Region, From 2019-2024 ( USD Billion )
  41. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  42. U.K. Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  43. U.K. Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  44. Germany Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  45. Germany Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  46. France Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  47. France Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  48. Italy Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  49. Italy Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  50. Spain Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  51. Spain Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  52. Asia-Pacific Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  53. Asia-Pacific Biosimilars Market By Region, From 2019-2024 ( USD Billion )
  54. Asia-Pacific Simple Generics Market By Region, From 2019-2024 ( USD Billion )
  55. Asia-Pacific Super Generics Market By Region, From 2019-2024 ( USD Billion )
  56. Asia-Pacific Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  57. Asia-Pacific Cardiovascular Drugs Market By Region, From 2019-2024 ( USD Billion )
  58. Asia-Pacific Anti-Infective Drugs Market By Region, From 2019-2024 ( USD Billion )
  59. Asia-Pacific Anti-Arthritic Drugs Market By Region, From 2019-2024 ( USD Billion )
  60. Asia-Pacific Central Nervous system Drugs Market By Region, From 2019-2024 ( USD Billion )
  61. Asia-Pacific Anti-Cancer Drugs Market By Region, From 2019-2024 ( USD Billion )
  62. Asia-Pacific Respiratory Products Market By Region, From 2019-2024 ( USD Billion )
  63. Asia-Pacific Others Market By Region, From 2019-2024 ( USD Billion )
  64. Japan Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  65. Japan Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  66. China Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  67. China Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  68. India Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  69. India Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  70. Australia Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  71. Australia Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  72. South Korea Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  73. South Korea Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  74. Latin America Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  75. Latin America Biosimilars Market By Region, From 2019-2024 ( USD Billion )
  76. Latin America Simple Generics Market By Region, From 2019-2024 ( USD Billion )
  77. Latin America Super Generics Market By Region, From 2019-2024 ( USD Billion )
  78. Latin America Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  79. Latin America Cardiovascular Drugs Market By Region, From 2019-2024 ( USD Billion )
  80. Latin America Anti-Infective Drugs Market By Region, From 2019-2024 ( USD Billion )
  81. Latin America Anti-Arthritic Drugs Market By Region, From 2019-2024 ( USD Billion )
  82. Latin America Central Nervous system Drugs Market By Region, From 2019-2024 ( USD Billion )
  83. Latin America Anti-Cancer Drugs Market By Region, From 2019-2024 ( USD Billion )
  84. Latin America Respiratory Products Market By Region, From 2019-2024 ( USD Billion )
  85. Latin America Others Market By Region, From 2019-2024 ( USD Billion )
  86. Brazil Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  87. Brazil Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  88. Argentina Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  89. Argentina Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  90. Mexico Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  91. Mexico Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  92. Rest of Latin America Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  93. Rest of Latin America Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  94. Middle East & Africa Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  95. Middle East & Africa Biosimilars Market By Region, From 2019-2024 ( USD Billion )
  96. Middle East & Africa Simple Generics Market By Region, From 2019-2024 ( USD Billion )
  97. Middle East & Africa Super Generics Market By Region, From 2019-2024 ( USD Billion )
  98. Middle East & Africa Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  99. Middle East & Africa Cardiovascular Drugs Market By Region, From 2019-2024 ( USD Billion )
  100. Middle East & Africa Anti-Infective Drugs Market By Region, From 2019-2024 ( USD Billion )
  101. Middle East & Africa Anti-Arthritic Drugs Market By Region, From 2019-2024 ( USD Billion )
  102. Middle East & Africa Central Nervous system Drugs Market By Region, From 2019-2024 ( USD Billion )
  103. Middle East & Africa Anti-Cancer Drugs Market By Region, From 2019-2024 ( USD Billion )
  104. Middle East & Africa Respiratory Products Market By Region, From 2019-2024 ( USD Billion )
  105. Middle East & Africa Others Market By Region, From 2019-2024 ( USD Billion )
  106. Middle East Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  107. Middle East Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )
  108. Africa Generic Drugs Market By Type, From 2019-2024 ( USD Billion )
  109. Africa Generic Drugs Market By Therapeutic Drugs, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample